A Phase 2 Study of MM-141 Plus Nab-paclitaxel and Gemcitabine in Front-line Metastatic Pancreatic Cancer
Study Number: 

PH 269615

Phase: 
2
Trial categories: 
Pancreatic
Immunotherapy
Antibody therapy
Principal Investigator: